$Hive Blockchain (HIVE.US)$
HIVE Digital Technologies reported strong Q3 FY2025 results with total revenue of $29.2 million, including $26.7 million from digital currency mining and $2.5 million from high-performance computing (HPC). The company achieved net income of $1.3 million and Adjusted EBITDA of $17.3 million.
Key highlights include mining 322 Bitcoin during the...

$MaxCyte (MXCT.US)$
MaxCyte (MXCT) has entered into a strategic platform license agreement with TG Therapeutics for the use of MaxCyte's Flow Electroporation® technology and ExPERT™ platform. The partnership aims to support the development and commercialization of azer-cel, TG's allogeneic CD19 CAR T cell therapy program for autoimmune diseases.
Under the agreement, TG Therapeutics re...

$MGO Global (MGOL.US)$
MIAMI — LONDON, U.K. — ATHENS, Greece — (Globe Newswire) – February 5, 2025 – MGO Global Inc. (Nasdaq: MGOL), a digitally-native, lifestyle brand portfolio company, (“MGO,” “MGO Global” or the “Company”), and Heidmar, Inc., a global commercial and pool management business serving the drybulk, crude oil and refined petroleum product tanker market (“Heidmar”) via an asset light business model, today jointly announced that on February 4, 2025, the U.S....

$Inspira Technologies Oxy (IINN.US)$
Inspira Technologies (Nasdaq: IINN) announced positive initial results from its collaboration with Ennocure MedTech to develop a novel bio-electronic treatment for preventing bloodstream infections. The ex-vivo testing on porcine skin model demonstrated a 95% reduction in bacterial presence within 4 hours, maintaining effectiveness over 24 hours.
The innovative technology uses ...

$Greenwave Technology Solutions (GWAV.US)$
On February 10, 2025, Greenwave Technology Solutions, Inc. (the “Company”) and certain institutional and accredited investors (the “Purchasers”) entered into a securities purchase agreement (the “Purchase Agreement”), pursuant to which the Company agreed to sell to such Purchasers an aggregate of 21,100,000 shares (the “Shares”) of common stock, par value $0.001 per share, of the Company (the “Common Stock”), in a register...

$Hyliion (HYLN.US)$
Hyliion Holdings (NYSE American: HYLN) has announced its upcoming fourth-quarter and full-year 2024 financial results conference call and webcast, scheduled for February 26, 2025, at 10:00 a.m. CT / 11:00 a.m. ET. The company, which develops sustainable electricity-producing technology, will release its financial results after market close on February...

$Ocean Biomedical (OCEA.US)$
Ocean Biomedical's breakthrough in targeting CHi3L1 in EGFR-mutant lung cancer represents a potential paradigm shift in oncology treatment. The discovery that their immunotherapy candidates can restore sensitivity to osimertinib is particularly significant, as drug resistance remains one of the most challenging aspects of cancer treatment. E...